Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Ciprofloxacin dry powder inhaler and preparation method thereof

A technology of ciprofloxacin hydrochloride and dry powder inhaler, which is applied in the field of medicine and achieves the effects of increasing drug loading, meeting clinical treatment needs, and high emptying rate

Active Publication Date: 2018-11-09
SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Due to the limitations of the current research, a ciprofloxacin hydrochloride dry powder inhaler with good inhalation and emptying performance and high drug loading is urgently needed in the market.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ciprofloxacin dry powder inhaler and preparation method thereof
  • Ciprofloxacin dry powder inhaler and preparation method thereof
  • Ciprofloxacin dry powder inhaler and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] This embodiment prepares a kind of ciprofloxacin hydrochloride dry powder inhalation, which is composed of ciprofloxacin hydrochloride as the active ingredient, carrier mannitol and silk fibroin, and the mass percentages of the three are 20%, 40%, and 40% respectively. Drugs accounted for 20%.

[0047] The preparation method of above-mentioned ciprofloxacin hydrochloride dry powder inhalation comprises the steps:

[0048] (1) Dissolving silk fibroin in deionized water, adding ciprofloxacin hydrochloride and mannitol, and stirring to form a uniform solution;

[0049] (2) adopt spray drying technology to carry out spray drying to above-mentioned solution, obtain ciprofloxacin hydrochloride dry powder inhalation; Wherein the technological condition of spray drying is: inlet temperature (being drying temperature): 110 ℃; Atomization pressure: 15kPa; Liquid velocity: 8.30mL / min; solid-liquid content: 25mg / mL; gas flow: 0.60~0.65m 3 / min, the nozzle diameter is 0.71mm;

[...

Embodiment 2

[0052] This example prepares a ciprofloxacin hydrochloride dry powder inhaler, the components of which are basically the same as those in Example 1, the difference being that in the process conditions of spray drying, the inlet temperature is 120°C.

Embodiment 3

[0054] In this example, a ciprofloxacin hydrochloride dry powder inhaler was prepared, the components of which were basically the same as those in Example 1, the difference being that in the process conditions of spray drying, the inlet temperature was 130°C.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a ciprofloxacin dry powder inhaler and a preparation method thereof. The dry powder inhaler is prepared from a drug and a binary auxiliary material, wherein the drug accounts for 80 to 20 percent by mass of the dry powder inhaler, the binary auxiliary material accounts for 20 to 80 percent by mass of the dry powder inhaler, and the binary auxiliary material comprises a mucus diluting agent and biological adhesive protein; the mucus diluting agent is at least one of mannitol, ambroxol hydrochloride, aminothiopropionic acid, and bromhexine hydrochloride; and the biological adhesive protein is at least one of silk fibroin, albumin or spidroin. The dry powder inhaler prepared by the invention is good in mobility, good in aerodynamic performance, capable of targeting thedrug to lung and capable of effectively increasing the local concentration of the drug, has mucus diluting and biological mucosa adsorption characteristics, and is particularly suitable for a patientwith bronchiectasia caused by the chronic infection of the lung.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a ciprofloxacin hydrochloride dry powder inhaler and a preparation method thereof. Background technique [0002] Bronchiectasis is a clinically very common respiratory disease, which occurs in patients with chronic pulmonary infection, especially chronic obstructive pulmonary disease (COPD) and cystic fibrosis (Cystic Fibrosis, CF). ) patients are more common. The condition of such patients is characterized by repeated inflammation and infection of the lungs, forming a vicious cycle. Repeated inflammation and infection of the lungs cause the mucus layer of the mucous membrane to thicken, which provides a good nutritional environment for the growth of bacteria, and at the same time forms a mucosal barrier to reduce the therapeutic effect of drugs. [0003] The treatment of inhaled antibiotics has become one of the first choice clinical treatment options for the trea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/72A61K9/14A61K47/42A61K47/26A61K31/496A61P11/00A61P31/04
CPCA61K9/0075A61K9/145A61K9/146A61K31/496A61K47/26A61K47/42A61P11/00A61P31/04
Inventor 刘春霞林玲李国成吕立余晓霞吴巧利林英周永恒
Owner SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com